We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-11.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$10.6B
AUM Growth
-$1.52B
Cap. Flow
+$47.1M
Cap. Flow %
0.44%
Top 10 Hldgs %
18.51%
Holding
395
New
8
Increased
194
Reduced
112
Closed
28

Top Sells

Rank Stock Value
1
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$66.2M
2
MTB icon
M&T Bank
MTB
+$43.8M
3
BKR icon
Baker Hughes
BKR
+$38.3M
4
ORCL icon
Oracle
ORCL
+$36.5M
5
CDK
CDK Global, Inc.
CDK
+$35.6M

Sector Composition

Rank Sector Weight
1 Technology 19.35%
2 Healthcare 17.05%
3 Financials 15.67%
4 Industrials 13.84%
5 Consumer Discretionary 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKC icon
201
McCormick & Company Non-Voting
MKC
$13.9B
$10.1M 0.1%
121,567
-2,768
-2% -$262K
CVS icon
202
CVS Health
CVS
$140B
$9.82M 0.09%
105,953
+9,427
+10% +$920K
CAC icon
203
Camden National
CAC
$977M
$9.31M 0.09%
211,314
+1,559
+0.7% +$70K
AVB icon
204
AvalonBay Communities
AVB
$27.2B
$8.99M 0.08%
46,275
+1,025
+2% +$222K
EMR icon
205
Emerson Electric
EMR
$85B
$8.95M 0.08%
112,555
+730
+0.7% +$64.4K
INTC icon
206
Intel
INTC
$435B
$8.77M 0.08%
234,545
+35
+0% +$1.51K
VOO icon
207
Vanguard S&P 500 ETF
VOO
$971B
$8.5M 0.08%
24,500
+2,215
+10% +$834K
VSGX icon
208
Vanguard ESG International Stock ETF
VSGX
$6.42B
$8.42M 0.08%
171,736
-28,315
-14% -$1.49M
AMGN icon
209
Amgen
AMGN
$212B
$8.4M 0.08%
34,535
-3,842
-10% -$941K
ISRG icon
210
Intuitive Surgical
ISRG
$130B
$8.3M 0.08%
41,378
-6,981
-14% -$1.64M
AME icon
211
Ametek
AME
$55.3B
$7.88M 0.07%
71,690
+28,365
+65% +$3.45M
GABC icon
212
German American Bancorp
GABC
$1.92B
$7.45M 0.07%
217,904
+1,354
+0.6% +$49.1K
ULTA icon
213
Ulta Beauty
ULTA
$21.6B
$7.37M 0.07%
19,120
+100
+0.5% +$39.7K
HON icon
214
Honeywell
HON
$78.3B
$7.09M 0.07%
43,285
-85
-0.2% -$15.3K
SWK icon
215
Stanley Black & Decker
SWK
$14.6B
$6.68M 0.06%
63,678
+24,315
+62% +$2.99M
EQNR icon
216
Equinor
EQNR
$90.9B
$6.64M 0.06%
191,000
+11,000
+6% +$393K
VRSK icon
217
Verisk Analytics
VRSK
$27.8B
$6.54M 0.06%
37,781
+3,317
+10% +$619K
RY icon
218
Royal Bank of Canada
RY
$295B
$6.46M 0.06%
66,775
+8,475
+15% +$867K
O icon
219
Realty Income
O
$61.3B
$5.95M 0.06%
87,205
-1,635
-2% -$112K
ABT icon
220
Abbott
ABT
$187B
$5.94M 0.06%
54,678
-480
-0.9% -$54.5K
ARE icon
221
Alexandria Real Estate Equities
ARE
$9.41B
$5.83M 0.06%
40,175
+6,750
+20% +$1.15M
TJX icon
222
TJX Companies
TJX
$178B
$5.8M 0.05%
103,827
-75,428
-42% -$4.57M
DGX icon
223
Quest Diagnostics
DGX
$26B
$5.74M 0.05%
43,145
-1,080
-2% -$147K
ANSS
224
DELISTED
Ansys
ANSS
$5.69M 0.05%
23,794
+5,125
+27% +$1.36M
INTU icon
225
Intuit
INTU
$85.6B
$5.64M 0.05%
14,637
-14,011
-49% -$5.8M

Similar funds

Boston Trust Walden's Q2 2022 Portfolio in Review

As of Q2 2022, Boston Trust Walden held 395 positions worth $10.6B, down 13% from $12.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden's Q2 2022 filing shows 8 new, 194 increased, 112 reduced and 28 closed positions. Its largest new stake was Core Laboratories: 1,993,528 shares worth $39.5M. The largest sale was ASPEN TECHNOLOGY INC, an estimated $66.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Boston Trust Walden's largest Q2 2022 buy was Core Laboratories: 1,993,528 shares worth $39.5M.
  • Boston Trust Walden added most to Americold in Q2 2022, an estimated $32.5M increase.
  • Boston Trust Walden's biggest Q2 2022 reduction was M&T Bank, cutting an estimated $43.8M.
  • Boston Trust Walden fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $66.2M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $10.6B portfolio in Q2 2022.
  • Boston Trust Walden opened 8 new positions and closed 28 in Q2 2022.
  • Boston Trust Walden's portfolio value fell 13% quarter-over-quarter to $10.6B.

Based on Boston Trust Walden's 13F filing for Q2 2022, filed 22 Jul 2022.